Supplemental material
Human Vaccines & Immunotherapeutics
Volume 18, 2022 - Issue 5
Pneumococcal – Research Paper
A cost-effectiveness analysis of PHiD-CV compared to PCV13 in a national immunization program setting in Tunisia
Youness Lagoubia GSK, Casablanca, MoroccoCorrespondence[email protected]
https://orcid.org/0000-0002-4153-1647View further author information
https://orcid.org/0000-0002-4153-1647View further author information, Mohamed Tahar Sfarb Department of Paediatrics, Tahar Sfar University Hospital, Mahdia, Tunisiahttps://orcid.org/0000-0003-3153-0357View further author information
https://orcid.org/0000-0003-3153-0357View further author information & Jorge A. Gomezc GSK, Buenos Aires, Argentinahttps://orcid.org/0000-0001-5459-4973View further author information
https://orcid.org/0000-0001-5459-4973View further author information